PGP and cancer: For that reason, we examined the protein expression of P-gp by immunoblotting with specific antibodies after treating P-gp-overexpressing NCI-ADR-RES and KB-V-1 cancer cells with branebrutinib (1–10 μM) for 72 h as described in Materials and methods.